Risk factorsBy Mayo Clinic Staff
Factors that can increase your risk of membranous nephropathy include:
Oct. 21, 2014
- Having a medical condition that can damage your kidneys. Certain diseases and conditions increase your risk of developing membranous nephropathy, such as lupus and other autoimmune diseases.
- Use of certain medications. Examples of medications that can cause membranous nephropathy include nonsteroidal anti-inflammatory drugs and gold salts.
- Exposure to certain infections. Examples of infections that increase the risk of membranous nephropathy include hepatitis B, hepatitis C and syphilis.
- Genetic background. Certain genetic factors make it more likely that you'll develop membranous nephropathy.
- Gilbert SJ, et al. National Kidney Foundation's Primer on Kidney Diseases. 6th ed. Philadelphia, PA.: Elsevier/Saunders; 2014. http://www.clinicalkey.com. Accessed Aug. 14, 2014.
- Cattran DC. Treatment of idiopathic membranous nephropathy. http://www.uptodate.com/home. Accessed Aug. 14, 2014.
- Beck LH, et al. Causes and diagnosis of membranous nephropathy. http://www.uptodate.com/home. Accessed Aug. 14, 2014.
- Nephrotic syndrome in adults. National Kidney and Urologic Diseases Information Clearinghouse (NKUDIC). http://kidney.niddk.nih.gov/kudiseases/pubs/nephrotic/. Accessed Aug. 28, 2014.
- Goldman L, et al. Goldman's Cecil Medicine. 24th ed. Philadelphia, Pa.: Saunders Elsevier; 2012. http://www.clinicalkey.com. Accessed Aug. 27, 2014.
- Herrmann SMS, et al. Membranous nephropathy: The start of a paradigm shift. Current opinion in nephrology and hypertension. 2012;21:203.
- Glomerular filtration rate (GFR). National Kidney Foundation. http://www.kidney.org/atoz/content/gfr.cfm. Accessed Sept. 3, 2014.
- Hogan J, et al. Diagnostic tests and treatment options in glomerular disease: 2014 update. American Journal of Kidney Diseases. 2014;63:656.
- Hofstra JM, et al. Treatment of idiopathic membranous nephropathy. Nature Reviews Nephrology. 2013;9:443.
- Riggin EA. Decision Support System. Mayo Clinic, Rochester, Minn. June 20, 2014.
- Fervenza FC (expert opinion). Mayo Clinic, Rochester, Minn. Sept. 6, 2014.
- Anti-PLA2R assay guidance. The Renal Association. http://rarerenal.org/clinician-information/membranous-nephropathy-clinician-information/anti-pla2r-assay-guidance/. Accessed Sept. 15, 2014.